Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

ZIOP

ZIOPHARM Oncology (ZIOP)

ZIOPHARM Oncology Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ZIOP
DatumZeitQuelleÜberschriftSymbolFirma
12/06/202322h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZIOPZIOPHARM Oncology Inc
08/06/202323h25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZIOPZIOPHARM Oncology Inc
08/06/202323h24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZIOPZIOPHARM Oncology Inc
10/05/202313h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ZIOPZIOPHARM Oncology Inc
25/04/202323h07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ZIOPZIOPHARM Oncology Inc
19/04/202323h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZIOPZIOPHARM Oncology Inc
19/04/202322h31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ZIOPZIOPHARM Oncology Inc
14/04/202323h06Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ZIOPZIOPHARM Oncology Inc
04/04/202323h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZIOPZIOPHARM Oncology Inc
03/04/202314h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZIOPZIOPHARM Oncology Inc
07/03/202313h32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ZIOPZIOPHARM Oncology Inc
07/03/202313h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZIOPZIOPHARM Oncology Inc
14/02/202319h31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ZIOPZIOPHARM Oncology Inc
14/02/202319h19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ZIOPZIOPHARM Oncology Inc
09/01/202314h40Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZIOPZIOPHARM Oncology Inc
04/01/202322h53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZIOPZIOPHARM Oncology Inc
01/12/202222h06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZIOPZIOPHARM Oncology Inc
30/11/202223h12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZIOPZIOPHARM Oncology Inc
30/11/202223h10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ZIOPZIOPHARM Oncology Inc
29/11/202200h32Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ZIOPZIOPHARM Oncology Inc
14/11/202213h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZIOPZIOPHARM Oncology Inc
07/11/202214h10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZIOPZIOPHARM Oncology Inc
30/09/202214h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZIOPZIOPHARM Oncology Inc
21/09/202214h42Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZIOPZIOPHARM Oncology Inc
19/09/202222h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZIOPZIOPHARM Oncology Inc
19/09/202222h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZIOPZIOPHARM Oncology Inc
19/09/202222h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZIOPZIOPHARM Oncology Inc
19/09/202222h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZIOPZIOPHARM Oncology Inc
08/09/202212h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ZIOPZIOPHARM Oncology Inc
07/09/202222h17Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ZIOPZIOPHARM Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:ZIOP